TITLE

Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate

AUTHOR(S)

Pai, Sivakami A.; Hebri, Sudhira P.; Lootah, Afra M.

PUB. DATE

November 2012

SOURCE

Indian Journal of Ophthalmology;Nov2012, Vol. 60 Issue 6, p551

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

The purpose of this report is to evaluate the efficacy and safety of combined intravitreal injection of bevacizumab and intravitreal triamcinolone acetonide (IVTA) for recurrent inflammatory choroidal neovascular membrane (CNVM). It was a prospective interventional study of a young female, who was a known case of Vogt-Koyanagi-Harada syndrome. She presented with an inflammatory choroidal neovascualar membrane and signs of panuveitis in the right eye. She underwent a complete ophthalmic examination. She was given intravitreal injection of bevacizumab and IVTA at different sites. There was complete regression of CNVM and ocular inflammation within a week. After six months, she had recurrence of CNVM in the same eye, which was treated similarly. There was a complete resolution of CNVM and ocular inflammation after the combination therapy and systemic steroids, until one year of follow-up. No serious systemic or ocular adverse events were noted. Combination therapy appears to be an effective and safe method in the management of recurrent inflammatory CNVM.

ACCESSION #

84538419

 

Related Articles

• One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation. Shirakata, Yukari; Shiragami, Chieko; Yamashita, Ayana; Nitta, Eri; Fujiwara, Atsushi; Shiraga, Fumio // Japanese Journal of Ophthalmology;Nov2012, Vol. 56 Issue 6, p599 

  Purpose: Our aim was to study the efficacy of combined triple therapy with intravitreal bevacizumab injections (IVB), posterior sub-Tenon injection of triamcinolone acetonide (STTA), and reduced laser fluence photodynamic therapy (RFPDT) in Japanese patients with retinal angiomatous...

• Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. el Matri, Leila; Chebil, Ahmed; Kort, Fadra; Bouraoui, Rym; Baklouti, Karim; Mghaieth, Fatma // Graefe's Archive of Clinical & Experimental Ophthalmology;Jun2010, Vol. 248 Issue 6, p779 

  To discuss the effect and outcome of a combined intravitreal triamcinolone acetonide (IVTA) injection with intravitreal bevacizumab (IVB) in treating choroidal neovascularization (CNV) associated with large retinal pigment epithelial detachment (PED) in age-related macular degeneration (AMD)....

• Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Yeo Jue Byun; Mi In Roh; Sung Chul Lee; Hyoung Jun Koh // Graefe's Archive of Clinical & Experimental Ophthalmology;Jul2010, Vol. 248 Issue 7, p963 

  To compare visual outcomes after intravitreal triamcinolone acetonide (IVTA) injection and intravitreal bevacizumab (IVB) administration for treatment of macular edema associated with branch retinal vein occlusion (BRVO). A retrospective comparative case series of 134 consecutive patients that...

• Comparison of the In-Vitro Effects of Bevacizumab, Mitomycin-C, 5-Fluorouracil, and Triamcinolone Acetonide on the Viability of Cultured Human Tenon's Fibroblasts. Ocampo, Pius Jonas; Lat-Luna, Maria Margarita; Tumbocon, Joseph Anthony; Chao-Po, Polly; Martin, Andrei // Philippine Journal of Ophthalmology;Jul-Dec2014, Vol. 39 Issue 2, p84 

  Objective: To evaluate and compare the effects of bevacizumab, mitomycin-C (MMC), 5-fluorouracil (5-FU), and triamcinolone acetonide (TA) on the viability of cultured human Tenon's capsule fibroblasts (cHTF) in vitro. Methods: Human Tenon's fibroblasts (HTF) were harvested and cultured in a...

• Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis. Roesel, M.; Gutfleisch, M.; Heinz, C.; Heimes, B.; Zurek-Imhoff, B.; Heiligenhaus, A. // Eye;Apr2009, Vol. 23 Issue 4, p910 

  PurposeTo evaluate the effect of orbital floor triamcinolone acetonide (OFTA) injections on inflammation and visual acuity in active non-infectious uveitis.MethodsMonocentre, retrospective study in 94 eyes (86 patients) with acute non-infectious uveitis receiving a single OFTA (40 mg) injection....

• Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection. Ji Song; Young Hong // Graefe's Archive of Clinical & Experimental Ophthalmology;Dec2008, Vol. 246 Issue 12, p1775 

  Abstract Background  We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis (ASPPC) that developed after intravitreal triamcinolone acetonide (IVTA) injection. Methods  Case report. Results  Two patients...

• Safety concerns exist when adding bevacizumab to intraperitoneal chemotherapy. Konner, JA // Hem/Onc Today;12/25/2011, Vol. 12 Issue 24, p19 

  The article reports on the safety concerns surrounding associated adverse events when adding bevacizumab to intraperitoneal chemotherapy, according to the results of a study published in the 2011 issue of the "Journal of Clinical Oncology."

• Bevacizumab and Triamcinolone Acetonide for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Antivascular Endothelial Growth Factors. Veritti, Daniele; Sarao, Valentina; Lanzetta, Paolo // Journal of Ocular Pharmacology & Therapeutics;May2013, Vol. 29 Issue 4, p437 

  Purpose: To evaluate the safety and efficacy of a combined approach using an antivascular endothelial growth factor (VEGF) agent (bevacizumab) and a steroid (triamcinolone acetonide) for treating choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) unresponsive to...

• Intravitreal Triamcinolone Acetonide Injection for Macular Edema Due to Central Retinal Vein Occlusion Persisting Despite Multiple Intravitreal Bevacizumab Injections. Alshareef, Rayan A.; Garg, Sunir J.; Hsu, Jason; Vander, James; Park, Carl; Spirn, Marc J. // Journal of Ocular Pharmacology & Therapeutics;Jul/Aug2014, Vol. 30 Issue 6, p512 

  Purpose: To evaluate the response to intravitreal triamcinolone acetonide for macular edema persisting or recurring despite multiple intravitreal bevacizumab (IVB) treatments for central retinal vein occlusion (CRVO). Methods: Retrospective interventional case series of 21 eyes with CRVO from 21...

Read the Article